We came across a bullish thesis on Eli Lilly and Company on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company's share was trading at $1,039.51 as of January 27th. LLY’s trailing and forward P/E were 50.93 and 31.65 respectively according to Yahoo Finance.
[caption id="attachment_1121838" align="aligncenter" width="640"]Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.